Filing Details
- Accession Number:
- 0001179110-20-008275
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-15 19:16:43
- Reporting Period:
- 2020-04-13
- Accepted Time:
- 2020-07-15 19:16:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1604821 | Natera Inc. | NTRA | Services-Medical Laboratories (8071) | 010894487 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1646382 | Matthew Rabinowitz | C/O Natera, Inc., 201 Industrial Road Suite 410 San Carlos CA 94070 | Executive Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-04-13 | 307 | $0.00 | 1,110,112 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2020-07-13 | 307 | $0.00 | 1,110,419 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-07-14 | 108 | $45.98 | 1,110,311 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Restricted Stock Unit | Disposition | 2020-04-13 | 307 | $0.00 | 307 | $0.00 |
Common Stock | Restricted Stock Unit | Disposition | 2020-07-13 | 307 | $0.00 | 307 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
2,456 | No | 4 | M | Direct | ||
2,149 | No | 4 | M | Direct |
Footnotes
- Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting April 13, 2019.
- Each RSU represents a contingent right to receive one share of the common stock of the issuer.
- The number of shares reported in Column 5 is the number of shares beneficially owned as of the date of this filing and takes into account transactions reported on Form 4 since the date of this transaction.
- The sale of shares was effected in order to satisfy tax liabilities due at the time of vesting.
- The RSUs vest over four years. 25% of the RSUs vest on April 13, 2019 and the remaining shares vest in 12 equal quarterly installments thereafter.